BDTX
Black Diamond Therapeutics Inc
Price:  
2.44 
USD
Volume:  
359,503.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BDTX WACC - Weighted Average Cost of Capital

The WACC of Black Diamond Therapeutics Inc (BDTX) is 7.2%.

The Cost of Equity of Black Diamond Therapeutics Inc (BDTX) is 10.75%.
The Cost of Debt of Black Diamond Therapeutics Inc (BDTX) is 5.00%.

Range Selected
Cost of equity 8.80% - 12.70% 10.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 8.2% 7.2%
WACC

BDTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.06 1.41
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 12.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 8.2%
Selected WACC 7.2%